Deals In Depth: June/July 2014
Executive Summary
For $635 million, Baxter acquired two marketed infectious vaccines from Pfizer; after five offers, Shire accepted AbbVie’s bid for $53.3 billion. Biopharma firms raised a total of $5.7 billion in June and July, while device companies raked in $924 million.